← FDA Drug Approvals (Drugs@FDA)
LIRAGLUTIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ORBICULAR · Approved 2026-01-14
Drug application
- FDA Application #
ANDA217590- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LIRAGLUTIDE
- Generic name
- LIRAGLUTIDE
- Active ingredients
- LIRAGLUTIDE
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- ORBICULAR
- Manufacturer
- Orbicular Pharmaceutical Technologies Private Limited
- First approval
- 2026-01-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown